COVID-19

Many living in lower-income rural populations face significant unmet social needs that can bar access to important mental health services.

The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.

Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.

The approval makes remdesivir the first and only approved antiviral treatment for patients across all stages of renal disease.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

Using artificial intelligence to sort and respond to patient queries could streamline processes and alleviate provider burnout.

Older adults are vulnerable to severe influenza-associated complications and risks, but influenza vaccines may be less effective in this population.

Pre-exposure prophylaxis of neutralizing SARS-CoV-2 monoclonal antibodies may be preventative against SARS-CoV-2 transmission, decreasing frequency of new infections and number of hospitalized patients who need antiviral therapies, thus lowering costs.

COVID-19 is helping to shape current pharmacy practice, including increased vaccinations, access to care, and better interactions with patients.

By empathizing with patients and creating an environment where patients feel comfortable and open to sharing, pharmacists can increase compliance and adherence.

The study also found significant evidence of outcomes disparities between minority populations and White populations.

During the pandemic, many community pharmacists also gained the authority to provide routine vaccinations for child populations.

OTC cases focus on recommendations for vaccination boosters and managing fever.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Novavax announced the development of a protein-based monovalent XBB COVID-19 vaccine with the intention of it being manufactured and available for the fall vaccination campaign.

Investigators found that individuals who received metformin were approximately 40% less likely to develop long COVID than those who received a placebo.

Health care professionals can provide patients with tips on appropriate hand sanitizer use, as well as product recommendations.

In-person visits to receive oral therapy, outpatient infusions, and inpatient infusion for the treatment of hematologic neoplasms declined in the early months of the COVID-19 pandemic, while telemedicine use increased slightly in the same period but remained low overall.

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.

There may be more than 200 symptoms associated with long COVID-19.

It’s imperative to redefine the future of pharmacy to help ensure a robust pipeline of future pharmacists and create a culture that helps ensure pharmacists live their purpose and passion.